Breaking News

Advanced Clinical Adds Exec Director

By Gil Roth | October 17, 2012

Paulson to lead clinical pharmacology, nonclinical development

Susan Paulson, Ph. D., has been named executive director, Clinical Pharmacology and Nonclinical Development at Advanced Clinical. Dr. Paulson is an accomplished clinical pharmacology professional who most recently ran her own consultancy, Paulson PK Consulting, LLC, which provided clinical pharmacology and nonclinical ADME expertise to the biotechnology and pharmaceutical industries. Prior to that, she provided pharmacology leadership at Abbott, NeoPharm, and Searle.

“We are very excited to welcome Susan's leadership to the Advanced Clinical team,” said Dr. Christina Fleming, chief scientific officer for Advanced Clinical. “Susan's diverse knowledge and expertise in the Clinical Pharmacology and Nonclinical research arena as well as her strong leadership skills are a perfect fit for Advanced Clinical’s mission and values.”

Leo Sheridan, chief executive officer of Advanced Clinical, echoes Dr. Fleming’s sentiment, noting, “We are honored to bring Susan’s caliber and experience to our team as we expand our CRO solutions.”

Related Compliance:

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research